Clinical Trial Update: REEV SENSE for Gait Analysis in Post-stroke Gait Impairment (SENS-AG) [NA]

View source ↗

Summary

A completed clinical trial evaluating the REEV SENSE gait analysis system for post-stroke gait impairment (SENS-AG).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gait Disorders Neurologic
• Stroke

Snippet

Sponsor: REEV LLC | Conditions: Stroke, Gait Disorders, Neurologic | NA | Status: COMPLETED